Getty Images

No. 50 Amerisource-Bergen

Pharmaceuticals
ABC
Value of investment: $21,491.91*

5-year return: 114.9%
2009 revenues: $71.8 billion
2009 net income: $503.4 million

AmerisourceBergen distributes branded and generic drugs and related products to doctors, hospitals, and pharmacies. Thanks in part to strong generic drug sales, CEO R. David Yost expects 8 to 10 percent revenue growth in 2010.

*For all slides as of 3/31/10

next slide previous slide